Disparities in subgroup populations enrolled in lung cancer trials. - Wikidata - awgldk - TriplyDB

Disparities in subgroup populations enrolled in lung cancer trials.

Disparities in subgroup populations enrolled in lung cancer trials.

http://www.wikidata.org/entity/Q37997817

about

Disparities in subgroup populations enrolled in lung cancer trials.

http://www.wikidata.org/entity/Q37997817

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Disparities in subgroup populations enrolled in lung cancer trials.

@en

Disparities in subgroup populations enrolled in lung cancer trials.

@nl

type

label

Disparities in subgroup populations enrolled in lung cancer trials.

@en

Disparities in subgroup populations enrolled in lung cancer trials.

@nl

prefLabel

Disparities in subgroup populations enrolled in lung cancer trials.

@en

Disparities in subgroup populations enrolled in lung cancer trials.

@nl

P1433

Q37997817-BB04B90E-9DDA-482F-B2FA-8EB02D4F87B4

P1476

Q37997817-B14D15B5-2181-4880-9443-FF49135A4A11

P2093

Q37997817-4CBA5EBF-4748-47A1-BBDD-F4C0959934D5

Q37997817-A3119624-6EE9-49FD-A2E8-E875E8EB569E

P2860

Q37997817-013E2065-15A7-4316-8233-AEE8490BD791

Q37997817-03D9D313-40C4-449F-8723-5362515C9127

Q37997817-0B27FD31-48DD-42C5-B95A-A00E27FB2D02

Q37997817-12BBD0DF-2745-4262-B74A-B06D397D6F80

Q37997817-1BC24F98-DD15-4897-A3DF-133708F09F17

Q37997817-1FF1C950-7D1A-4EEC-AA94-45F1F3F67D0F

Q37997817-2039ED5D-BF99-4541-9DC4-8BC1D29088C6

Q37997817-2482A18E-A29B-4D28-93C7-00D982680364

Q37997817-2AB3D353-036C-4168-AC84-DE2D358979FA

Q37997817-2B163B7A-BA5C-4C0C-B701-1B94C5339BF1

P304

Q37997817-F115A5D4-E525-4949-8B23-DB43F3E5AD26

P31

Q37997817-FD4AE9DE-DEFA-4F79-87E4-865CD8BA9929

P356

Q37997817-BCEA18EE-9411-4CC2-A59D-2DBB238A11D0

P433

Q37997817-18E9496C-2385-4874-A878-B98E7033D053

P478

Q37997817-10D39057-9C6E-4D80-84B6-F9810014AD4E

P50

Q37997817-08703381-A479-4607-BDAE-EC4540192398

P577

Q37997817-4FE74757-CFCE-401C-8793-64FE56A8D7C2

P698

Q37997817-DFD05713-9FA0-4D2F-8267-EFFE5401E58F

P356

P1433

Expert Review of Respiratory Medicine

P1476

Disparities in subgroup populations enrolled in lung cancer trials.

@en

P2093

Domenico Galetta

http://www.w3.org/2001/XMLSchema#string

Giovanni Palazzolo

http://www.w3.org/2001/XMLSchema#string

P2860

Why genes don't count (for racial differences in health)

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Erlotinib in previously treated non-small-cell lung cancer

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

P304

163-172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERS.12.10

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22455489

http://www.w3.org/2001/XMLSchema#string